Abstract--This study examined the distribution of muscarinic acetylcholine receptor-immunoreactive neurons in the amygdaloid complex of the rat, with emphasis on the central nucleus. The monoclonal antibody M35 raised against purified muscarinic acetylcholine receptor protein was used to visualize muscarinic acetylcholine receptor-immunoreactive cells. Muscarinic acetylcholine receptor immunoreactivity was high in the central nucleus and low to moderate in all other regions of the amygdaloid complex. Within the central nucleus, the muscarinic acetylcholine receptor-immunoreactive neurons were found predominantly in the lateral subdivision. This region contained medium-sized neurons (largest diameter ranging from 10 to 15 µm), with a round or slightly ovoid cell shape. At the subcellular level, however, the labeled neurons revealed relatively few muscarinic acetylcholine receptor-immunoreactive postsynaptic densities. Immunofluorescent double-labeling demonstrated that nearly all of the muscarinic acetylcholine receptor-immunoreactive neurons (98.6%) in the central nucleus expressed abundant amounts of nicotinic acetylcholine receptors, further substantiating the cholinoceptive character of these cells. In addition, the vast majority of these muscarinic acetylcholine receptor-immunoreactive neurons (94.3%) were GABAergic neurons. The muscarinic acetylcholine receptor-immunoreactive neurons expressed moderate levels of protein kinase C , one of the likely intracellular mediators between muscarinic acetylcholine receptors and their elicited physiological response. The number and staining intensity of muscarinic acetylcholine receptor-immunoreactive neurons in the central nucleus varied dramatically among rats. This individual variation correlated positively with the rat's expression of conditioned immobility and correlated negatively with active shock avoidance performance.
There is ample evidence that the amygdala is critically involved in a variety of functions such as learning and memory, attention, stress and fear (for review see Ref. 2) . Within the amygdaloid complex, the central nucleus of the amygdala (CEA) plays a pivotal role in the expression of the fear response. 5, 14, 29, 43, 45 Aversive information is directly projected to the lateral part of this area, 7, 14, 15 and lesions of the CEA result in a decreased expression of fear responses, as well as fear-elicited analgesia. 21, 22, 26, 27, 41, 42, 58 Injections of the cholinergic agonist carbachol within and adjacent to the CEA induce increases in immobility (a fear-induced behavior), 35 and blockade of cholinergic neurotransmission in the CEA inhibits anxiety-related behaviors. 28 These results suggest a role of the cholinergic system in fear-induced behaviors. The numerous subregions of the rat amygdaloid complex receive different levels of cholinergic innervation. 24, 25 Relative little information, however, is available about the origin of the cholinergic innervation of the CEA. The cholinergic fibers innervating the CEA do not contain nerve growth factor receptors, suggesting that the innervation arises from either the nerve growth factor receptor-negative neurons of the nucleus basalis 24 or the upper brainstem. 36, 37, 60 Alternatively, intrinsic amygdaloid cholinergic neurons, notably present in the lateral and medial parts, but absent in the central zone of the CEA, 34 may also provide the CEA with its cholinergic innervation.
The changes in fear-induced behaviors elicited by carbachol injections within and adjacent to the CEA were inhibited by pretreatment with the muscarinic *To whom correspondence should be addressed. Abbreviations: CEA, central amygdala; DAB, diaminobenzidine; GAD, glutamate decarboxylase; IR, immunoreactive; mAChR, muscarinic acetylcholine receptor; nAChR, nicotinic acetylcholine receptor; PBS, phosphate-buffered saline; PKC , protein kinase C ; RT, room temperature.
antagonist atropine, but not with the nicotinic antagonist hexamethonium, suggesting a selective role of muscarinic acetylcholine receptors (mAChRs). 35 Receptor autoradiography and in situ hybridization for the mAChR subtypes m1-m4 showed the presence of mAChRs in the amygdaloid complex, including the CEA. 9, 32, 46 However, to date no detailed information is available on the muscarinic cholinoceptive neurons of the amygdala. The aim of the present study was to examine the cellular distribution of mAChRs in the amygdala in more detail, with emphasis on the CEA. The mAChRs were visualized by employing the extensively characterized monoclonal antibody M35 raised against purified mAChR protein from bovine forebrain homogenates. 3, 4, 50, 54, 56 Advantages of receptor immunocytochemistry over autoradiography are that it reveals a higher resolution, and the subcellular distribution of mAChR protein can be studied at the electron microscopic level. In addition, immunofluorescent double-labeling can be performed to study the neurochemical content of mAChRimmunoreactive (IR) neurons in the CEA for the presence of functionally relevant signal transduction proteins. To further substantiate the cholinoceptive nature of the M35-positive neurons in the CEA, a co-localization study was carried out with WF6, a monoclonal antibody raised against the nicotinic acetylcholine receptor (nAChR). 19, 55 Previously, we demonstrated that muscarinic cholinoceptive neurons were typically characterized by the expression of the GABA-synthesizing enzyme glutamate decarboxylase (GAD) 52 and protein kinase C (PKC ), 56 a key enzyme for signal transduction and neuronal plasticity involved in mediating cholinergic neurotransmission. The relation between GAD, PKC and mAChRs in the CEA was therefore also studied.
Preliminary data revealed a high degree of individual variation in number and staining intensity of mAChR-immunopositive neurons in the CEA. In order to examine whether this variation correlates with certain types of behavior, two tasks were selected which require the CEA for proper performance: fear conditioning in a shuttle-box (active shock avoidance) and immobile behavior induced by the learned fear of an aversive stimulus (conditioned immobility).
EXPERIMENTAL PROCEDURES

Subjects
A total of 28 young adult male Wistar rats bred in our own facilities, weighing between 280 and 320 g, were used. They were group-housed in cages (40 60 15 cm) of five to seven rats and maintained on a 12:12 h light : dark schedule (lights on at 08.30) in a temperature-controlled environment of 21 1 C. Food and water were continuously available. Seven animals were used for light microscopic description of the distribution of mAChR immunoreactivity and fluorescence double-labeling experiments in the amygdala. In addition, four animals were used for an electron microscopic study of the labeling. For the behavioral experiments, animals were either exposed to the conditioned immobility task (n=7) or to the active shock avoidance paradigm (n=10). The behavioral experiments were carried out during the light period (09.00 and 15.00). All efforts were made to minimize animal suffering and to reduce the number of animals used.
Immunocytochemical staining procedure
Following anesthesia with sodium pentobarbital (90 mg/ kg, i.p.), fixation of the brain was carried out by transcardial perfusion of 300 ml fixation solution consisting of 2% paraformaldehyde, 0.05% glutaraldehyde and 0.2% picric acid in 0.1 M phosphate buffer at pH 7.4. Fixation was preceded by a pre-rinse with 50 ml saline solution at a perfusion speed of 25 ml/min. The brains were removed, stored overnight in 30% buffered sucrose at 4 C for cryoprotection and coronally sectioned on a cryostat microtome (n=24) or vibratome (n=4) at a thickness of 20 µm.
mAChRs were visualized by means of the monoclonal antibody M35. The M35 monoclonal immunoglobulin M antibody was raised in mice against muscarinic receptor protein purified from bovine forebrain homogenates. nAChRs were demonstrated with the monoclonal antibody WF6 (Dr H. Schrö der, Anatomical Institute, University of Cologne, Cologne, Germany), an immunoglobulin G directed to the -subunit of nicotinic receptors purified from the electric organ of Torpedo marmorata. 19 Further extensive descriptions of the production, characterization and use in immunocytochemistry of WF6 and M35 have been reported previously. 3, 4, 19, 54, 55 For M35 immunoreactivity, the brain sections were incubated overnight at 4 C in a primary antibody solution in phosphate-buffered saline (PBS), containing mouse immunoglobulin M antimAChR (M35, Chemunex, Paris, France; 1:200). Prior to both the primary and secondary antibody steps, the sections were preincubated in 5% normal rabbit serum. The primary antibody step was followed by exposure to biotinylated rabbit anti-mouse immunoglobulin M (Zymed, San Francisco, CA, U.S.A.; 1:200, 2 h at room temperature (RT)) and subsequently to streptavidin-horseradish peroxidase (Zymed; 1:200, 2 h at RT). Finally, the brain sections were processed using a diaminobenzidine (DAB)-H 2 O 2 reaction (30 mg DAB and 0.01% H 2 O 2 /100 ml Tris buffer), guided by a visual check. The cryostat sections were then mounted for light microscopic inspection. The DAB-processed Vibratome sections were postfixed with subsequent exposure to 1% OsO 4 for 1 h, dehydrated in an ascending series of ethanol, stained en bloc with 1% uranyl acetate in 70% ethanol and flat-embedded in Epon. Selected tissue blocks were cut to ultrathin sections and investigated in EM Philips 201 or 300 electron microscopes.
Co-localization studies for mAChRs with nAChRs, PKC or GAD were performed using immunofluorescent double-labeling. Preceding the primary and secondary antibody steps, the sections were preincubated in 5% normal serum (sheep, rabbit or goat, depending on the secondary antibody; see below). nAChRs were visualized by means of the monoclonal antibody WF6. Double-labeling experiments for the study of co-localization of nAChRs and mAChRs in the sequence of WF6/M35 were carried out. Free-floating brain sections were incubated overnight at 4 C with the primary antibody solution in PBS containing mouse anti-nAChR immunoglobulin G (WF6, 1:10). For WF6 the primary antibody step was followed by goat anti-mouse phycoerythrin-conjugated immunoglobulin G (Tago, San Mateo; 1:50, 2 h at RT). After completion of the WF6 staining, the sections were incubated with M35 as described above, followed by biotinylated rabbit anti-mouse immunoglobulin M (Zymed; 1:50, 2 h at RT) and fluorescein isothiocyanate-conjugated streptavidin (Zymed; 1:50, 2 h at RT). PKC was visualized employing the monoclonal 64 E. A. Van der Zee et al.
immunoglobulin G antibody 36G9, raised against purified bovine PKC protein. 11, 12 Fluorescent double-labeling experiments for the study of co-localization of PKC and mAChRs were carried out in the sequence of 36G9/M35. The primary antibody step with 36G9 (1:200) was followed by a 2-h incubation at RT in phycoerythrin-conjugated goat anti-mouse immunoglobulin G (Tago; 1:50). Upon completion of the 36G9 staining, the sections were incubated with M35 as described above. GAD was visualized using a rabbit anti-GAD antibody (K2, a generous gift of Dr A. J. Tobin, Department of Biology, University of California, Los Angeles, CA, U.S.A.). 18 The sections were exposed to K2 (1:100) overnight at 4 C with gentle movement. GAD incubation was followed by incubation with phycoerythrinconjugated goat anti-rabbit immunoglobulin G (Tago; 1:200, 2 h at RT). After completion of the first immunostaining, the sections were incubated with the monoclonal M35 as described above. All incubations with fluorescent labels were performed in the dark. After antibody processing the sections were mounted and coverslipped in a 1:1 mixture of PBS and glycerin. The sections were studied and photographed with a Ploemopak Leitz fluorescence microscope with the appropriate filter blocks for fluorescein isothiocyanate and phycoerythrin labels, yielding green and red fluorescence, respectively. Standard control experiments were performed by (i) omission of either or both primary antibodies in the incubation cycle, (ii) primary antibodies incubated with the non-matching secondary antibodies and (iii) replacing the primary antibody with normal mouse serum. In all cases the controls yielded negative results, i.e. the absence of any detectable labeling, which excluded the occurrence of possible cross-reactivity of secondary antisera during the incubation cycle.
Behavioral procedures
Active avoidance conditioning was performed in a shuttle-box, as described in detail elsewhere. 16 The sound of a buzzer served as the conditioning stimulus, presented for 5 s prior to the unconditioned stimulus of an electric footshock (0.25 mA a.c.) delivered through the grid floor of the shuttle-box. When the rats crossed the barrier within 5 s of conditioned stimulus presentation, the conditioned stimulus was terminated immediately, no footshock was applied and the response was recorded as an avoidance. If the rats failed to make the response within 10 s after the onset of the conditioned stimulus, both the conditioned and unconditioned stimuli were terminated. The animals received 60 trials in one daily session, with an intertrial interval of 20 s. The total number of correct avoidances of each animal was correlated with the number of mAChR-positive neurons in the CEA.
A step-through-type passive avoidance apparatus, as described by Ader et al., 1 was used to investigate conditioned immobility. Briefly, the apparatus consisted of a dark compartment (40 40 40 cm) connected via a small opening to an elevated, well-lit platform. A sliding door prevented access from the platform to the dark compartment. The floor of the dark compartment was made of stainless steel bars, through which a scrambled footshock was delivered. Five training trials were given in two days (two trials on the first day and three trials on the second day of training). Only the first trial started with a 3-min adaptation to the dark compartment. Immediately afterwards, the rat was placed on the illuminated platform and allowed to enter the dark compartment. The sliding door was closed afterwards and the rat stayed another 3 min in the dark. During the training trials the rat was placed directly on the illuminated platform; after entering, the animal was allowed to stay in the dark for 5 min. During the fifth trial each rat received an inescapable aversive stimulus of a scrambled electric footshock (0.6 mA a.c. for 3 s) immediately after entering the dark compartment. The rat was removed from the dark 60 s after termination of the footshock. Twentyfour hours later, the rat was placed directly in the dark compartment with the door closed (forced exposure), and the duration of immobile behavior, induced by the learned fear of the aversive stimulus, was measured during a 5-min recording time by direct observation. Immobility was defined as the animal being motionless and alert.
The animals were killed 2 h following completion of either task and processed for immunocytochemical staining. The behavioral response of each animal was correlated with the number of mAChR-positive neurons in the CEA.
Quantification of cell numbers
Cell counts of mAChR-positive neurons in the CEA were performed in six selected brain sections per animal, containing one section of the rostral, one of the caudal and four sections of the mid-level of the CEA. The rostral and caudal sections correspond to bregma levels 2.12 and 3.14 mm, respectively, according to the brain atlas of Paxinos and Watson.
38 mAChR-IR neurons were only counted when the nucleus was in the plane of section. The counts revealed no consistent left/right differences, and therefore the scores of both sides were summed. For quantification of the fluorescence double-labeling for mAChRs with nAChRs, PKC or GAD, two sections per animal containing the CEA at the mid-level (bregma level approximately 2.56 mm) were examined. Single-and double-labeled mAChR-positive neurons were counted in seven animals. A neuron was considered to be double-labeled if the cell body and/or dendritic processes revealed immunoreactivity for both markers. All counts of individual animals were summed and are presented in Table 1 .
Statistics
Correlation coefficients between the number of mAChRpositive cells and either the expression of conditioned immobile behavior or the number of correct avoidances were calculated using the Pearson rank correlation. A probability level of P<0.05 was taken as statistically significant.
RESULTS
Muscarinic acetylcholine receptor immunoreactivity in the amygdaloid complex
mAChR-IR neurons were scattered throughout the amygdaloid complex, with a low to moderate staining density in the basolateral and medial amygdala, and a high staining density in the CEA (Fig. 1A) . The labeled neurons in the CEA were often densely (Fig. 1B) . These neurons were medium-sized (largest diameter ranging from 10 to 15 µm), with a round or slightly ovoid cell shape. Almost every labeled cell contained one or more primary dendrites. The vast majority of mAChR-positive neurons was found in the lateral subdivision of the CEA, whereas the medial zone was devoid of mAChR immunoreactivity (Fig. 1A, Fig. 2B ). Most mAChR-positive neurons were found in the caudal half of the CEA. Some mAChR-IR astrocytes were encountered in all amygdala regions.
To study the subcellular distribution of mAChRs in CEA neurons in more detail, vibratome sections were obtained for electron microscope observations. Examination at the ultrastructural level revealed that in most cases the pattern of mAChR immunoreactivity could be characterized by an irregular patch-like arrangement over the cytoplasm of the cell soma, whereas the nucleus and the neuron's endoplasmic reticulum remained unstained (Fig. 1C) . Patches of mAChR immunoreactivity were associated with the Golgi apparatus. Numerous transected dendrites displayed dense cytoplasmic staining (Fig. 1D ). Relatively few labeled postsynaptic membrane densities, however, were seen in the cell body and dendrites. This is in contrast, for example, to the basolateral amygdala, where the cytoplasmic staining was less dense, but endowed with numerous immunoreactive postsynaptic membrane sites (data not shown).
Comparisons between the cases studied displayed a high degree of individual variation in number and staining intensity of mAChR-positive neurons (Fig.  2) . Cell counts in seven animals (six sections per animal; see Experimental Procedures) revealed that the number of labeled neurons could differ approximately two-fold in the extreme cases. On average, 614.2 ( 156.8 S.D.) immunopositive neurons were counted per individual in six sections containing the CEA, with 391 and 811 as the lowest and highest 
Neurochemistry of muscarinic acetylcholine receptorpositive neurons in the central amygdala
To study the neurochemical nature of the mAChRpositive neurons of the CEA, a series of immunofluorescent double-labeling experiments were performed with nAChRs, GAD and PKC (Table 1) . Nearly all mAChR-positive neurons also expressed nAChRs (Fig. 3A, B) . Of 1343 mAChR-positive neurons examined in seven animals, 1324 neurons (98.6%) were endowed with both types of cholinergic receptors. Single-labeled mAChR-or singlelabeled nAChR-positive neurons were only rarely encountered. Of 1222 muscarinic cholinoceptive cells, 1042 (85.3%) expressed PKC . In other words, the vast majority of muscarinic cholinoceptive cells expressed PKC (Fig. 3C, D) . However, most mAChRstained cells contained only moderate levels of PKC . Within the amygdaloid complex, the CEA was the nucleus with the highest number of GAD-positive neurons. A high degree of co-localization for mAChRs and GAD was found (Fig. 3E, F) . Of 1559 mAChR-positive cells, 1470 (94.3%) were found to be GAD-positive, indicating that they are GABAergic in nature. Taken together, these results show that the neurons densely stained for mAChRs are GABAergic interneurons expressing high numbers of nicotinic receptors, which are moderately endowed with the transduction protein PKC .
Correlations of behavioral performance and the number of muscarinic acetylcholine receptorimmunoreactive neurons in the central amygdala
Both behavioral tasks revealed a striking individual variation in performance. In the conditioned emotional task, the duration of immobility in rats ranged from 48 to 182 s (of a total of 300 s observation time). Between 12 and 44 correct active avoidances were observed during the session of 60 trials of active shock avoidance training. A remarkable observation in the shuttle-box was that animals that showed a low number of correct avoidances displayed high levels of immobility (data not shown). A positive correlation (r=0.980; P<0.0001) was found between the number of cholinoceptive cells in the CEA and the absolute time spent in immobile behavior in the conditioned emotional task (Fig. 4) . In contrast, the number of mAChR-IR cells was negatively correlated (r= 0.788; P<0.01) with the number of correct avoidances in the active shock avoidance test (Fig. 4) .
DISCUSSION
Cellular and subcellular distributions of muscarinic acetylcholine receptors in the central amygdala
The numerical density of mAChR-IR neurons scattered throughout the amygdala regions was greatest in the lateral aspect of the CEA. In addition, the staining intensity of these neurons was considerably higher than that of neurons in all other parts of the amygdala. At the subcellular level, patches of immunoreactivity in CEA neurons were present on the exterior side in the membrane pouches or vesicles, or associated with the cell's Golgi apparatus. This irregular cytoplasmic staining probably represents a highly specific staining of muscarinic receptor proteins at a certain stage of synthesis or membrane incorporation. Binding of M35 did not occur in the neuron's endoplasmic reticulum, suggesting that the antigenic determinants are not expressed in the early phase of formation of polypeptide chains. The specific pattern of immunoreactivity possibly indicates binding of M35 to an epitope on the receptor protein becoming recognizable in the final stages of protein synthesis. Another explanation for these mAChR immunoreactivity in the amygdala-Ifindings may be that, in the Golgi apparatus, the proteins are incorporated in membrane fragments, where the receptor proteins are molded into their receptor-specific configurations. An inverse relation between the level of immunoreactivity for mAChRs and the density of cholinergic innervation 24, 25 became apparent within the amygdaloid complex, i.e. a dense cholinergic innervation but moderate levels of mAChR immunoreactivity in the basolateral amygdala, and a sparse cholinergic innervation but high levels of mAChR immunoreactivity in the CEA. However, the number of mAChR-IR postsynaptic densities does correlate with the degree of cholinergic innervation; there are considerably more mAChR-labeled postsynaptic densities in the neurons of the basolateral amygdala than in the CEA. 54 This finding might suggest that non-synaptic neurotransmission may be the predominant type of cholinergic signal transduction in the CEA. Also, part of the intracellular mAChRs may represent spare receptors, since M35 localizes mAChR protein and not only the functional receptors. Interestingly, the level of mAChR immunoreactivity in the CEA is not necessarily regulated by the degree of cholinergic innervation, a finding which may add to the observed inverse relation between the degree of cholinergic innervation and mAChR immunoreactivity. Behaviorally induced enhancement of mAChRs in the somatosensory cortex was found to be independent of the presence of cholinergic innervation, 51 and cholinergic denervation of the neocortex did not result in a change in the level of mAChR immunoreactivity of the cortical target neurons 59 (Van der Zee E. A., unpublished observations). These data indicate that the regulation of mAChR protein may also be mediated by noncholinergic neurotransmission, determining the level of cholinoceptivity of the CEA neurons.
Specificity of the M35 monoclonal antibody
Although the exact epitope on the mAChR protein recognized by M35 is currently unknown, biochemical data have revealed that M35 most likely recognizes a conformational determinant only present on the active receptor. 3, 4 Furthermore, M35 acts as an agonist and mimics some physiological effects of acetylcholine. 30 Occupation of the agonist and antagonist binding sites on the mAChRs by specific ligands, however, could not block M35 binding. 56, 57 Recently, mAChR subtype selectivity of M35 was determined employing CHO-K1 cells stably expressing pure populations of human m1-m5 mAChR subtypes separately. These experiments showed that M35 binds to all five mAChR subtypes, whereas the non-transfected CHO-K1 control cells were immunonegative for M35. 10 The epitope for M35, therefore, must be localized on a part of the receptor with a high level of homology between the subtypes.
Neurochemical characterization of muscarinic acetylcholine receptor-immunoreactive neurons in the central amygdala
Immunofluorescent double-labeling revealed that the cholinoceptive neurons of the CEA are GABAergic cells, endowed with both muscarinic and nicotinic receptors. The nearly 100% degree of colocalization for M35 and WF6 found in the CEA resembled our findings in the neocortex, 55 and further substantiates the highly cholinoceptive nature of the CEA neurons currently under investigation.
Cholinergic-GABAergic interactions are widespread in the amygdaloid complex and other brain regions. 31, 34 As in the hippocampus and medial septum, 52, 53 GAD-positive neurons of the CEA express the highest amounts of mAChRs within the CNS. These observations suggest that GABAergic cells represent a main target of the cholinergic innervation in various brain areas. The distribution of GAD immunoreactivity in the lateral subdivision of the CEA in the present study closely resembled recently described distribution patterns for GABAergic cells. 47, 48 GABAergic neurons of the lateral subdivision of the CEA play a major role in the activity of the CEA output neurons of the medial subdivision of the CEA. 15, 47 The GABAergic/cholinoceptive neurons express PKC , which likely serves as a mediator between mAChRs and the physiological response elicited by mAChR stimulation. Neurochemically, these cells resemble interneurons in the hilar region of the hippocampus, which revealed changes in mAChR immunoreactivity induced by spatial orientation of subjects in a hole board task. 49 Recently, Brunner and Misgeld 8 demonstrated that mAChR stimulation of these neurons results in excitations. This excitatory effect may be mediated by the co-expressed PKC , and this protein may therefore play a critical role in the observed mAChR plasticity described in a forthcoming paper. 44 
Individual variation in the number of muscarinic acetylcholine receptor-immunoreactive neurons in the central amygdala and the correlation with fearinduced behavior
The number and staining intensity of mAChR-IR neurons in the CEA varies to a considerable degree among individual Wistar rats. This individual variation is already present in behaviorally naive animals, suggesting that it reflects an intrinsic characteristic of Wistar rats. The variation in the number of mAChR-IR neurons correlates with the variation in emotionally related behaviors. The correlations found implicate these cells in the expression of fear and associated immobility, and relate to the ability to cope with a stressful task. Rats with high levels of mAChRs spent more time in immobile behavior induced by the learned fear of an inescapable footshock. The reverse is true for active shock avoidance performance, which requires an active behavioral response, i.e. low levels of immobility. The CEA is a likely anatomical location to display neurochemical differences among individuals related to fear-induced immobility, since lesioning or chemical blockade of this area selectively impairs immobility. 40, 41 The initial steps of active shock avoidance acquisition involve an early conditioned emotional response, inducing a tendency to show immobility. 13, 20 It is clear from the genetically selected Roman high-and low-avoidance rats that avoidance performance in a two-way shuttle-box paradigm correlates negatively with immobility. 17 This may explain the inverse correlation of active shock avoidance with the numbers of mAChR-IR neurons in the CEA. In a forthcoming paper, 44 we demonstrate that it is fear (and not the cognitive aspects of the task) that determines the level of mAChR immunoreactivity in the CEA.
The present results suggest that a high level of mAChR immunoreactivity in the CEA is related to a highly responsive fear system, as measured by high levels of immobility. This view is consistent with the finding that immobile behavior is positively correlated with the level of central cholinergic activity in Tryon's maze rats. 6 Furthermore, intraperitoneal injections of the cholinergic antagonist scopolamine reduced immobile behavior in rats in a dose-related fashion. 33 mAChR stimulation by carbachol within and adjacent to the CEA induced an increase in immobile behavior, 35 whereas the blockade of preand/or postsynaptic mAChRs by atropine in the CEA decreased anxiety-related behavior. 28 The correlations observed in the present study predict that active shock avoidance acquisition will be improved by mAChR blockade, and impaired by mAChR stimulation in the amygdala. Indeed, Grossman 23 demonstrated that intra-amygdalar infusions of carbachol, or the acetylcholinesterase inhibitor eserine, dramatically diminished acquisition of active avoidance responses in rats, whereas rats injected with the muscarinic antagonist scopolamine outperformed normal controls. Long-lasting inhibition of acetylcholinesterase by intra-amygdala injection of fasciculin, however, did not result in changes in acquisition or retention in two avoidance tasks. 39 A down-regulation of 50% of the mAChRs in the amygdala observed in the latter study, compensating for the increased cholinergic activity, may possibly account for the negative results.
CONCLUSIONS
In summary, the lateral subdivision of the CEA contains the highest density of mAChR-IR neurons of the amygdaloid complex. These cholinoceptive neurons are GABAergic in nature, and their activation most likely results in inhibitory neurotransmission in the medial CEA. The number of GABAergic/ cholinoceptive neurons and their staining intensity for mAChRs vary among Wistar rats. Behavioral experiments implicate these cells in the expression of fear responses, and this cell group represents a neuronal substrate that correlates with the degree of immobile behavior. The results of the present study shed new light on the functional properties of muscarinic cholinoceptive neurons in the CEA and their contribution to fear-induced behaviors, and this cell group is the subject of further studies in our forthcoming paper. 44 
